Combined immunodeficiency-multiple intestinal atresia

Last reviewed

🖨 Print for my doctorAdvocacy Hub →
ORPHA:436252OMIM:243150Q82.8
Who is this for?
Show terms as
1FDA treatments8Treatment centers1Financial resources

Where are you in your journey?

UniteRare data is sourced from FDA.gov, ClinicalTrials.gov, Orphanet, OMIM, and NORD.
Report missing data

Overview

Combined immunodeficiency with multiple intestinal atresia (CID-MIA) is an extremely rare and serious condition that affects both the immune system and the digestive tract. Babies born with this disease have a severely weakened immune system, meaning their body cannot properly fight infections. At the same time, they are born with multiple blockages (called atresias) in their intestines, where sections of the bowel are closed off or missing. These blockages prevent food from passing through normally and require surgical intervention shortly after birth. Because the immune system is so severely compromised, affected infants are highly vulnerable to life-threatening infections from bacteria, viruses, and fungi. The intestinal problems cause difficulty feeding, vomiting, and a swollen belly soon after birth. Even with surgery to repair the intestinal blockages, the underlying immune deficiency remains a critical problem. Some babies also develop skin abnormalities. The treatment landscape for CID-MIA is very challenging. Surgical repair of the intestinal atresias is necessary but does not address the immune deficiency. Bone marrow transplantation (also called hematopoietic stem cell transplantation) has been attempted to restore immune function, but outcomes have historically been poor. Supportive care includes intravenous nutrition (called total parenteral nutrition or TPN), infection prevention, and immunoglobulin replacement therapy. Unfortunately, this condition carries a very high mortality rate in infancy, and there is currently no reliable cure for most patients.

Also known as:

Key symptoms:

Severe immune deficiency with frequent and serious infectionsMultiple blockages in the intestines present at birthSwollen or distended belly in the newborn periodVomiting of green bile-stained fluidInability to pass stool after birthFailure to gain weight and growChronic diarrheaSkin rashes or abnormal skin appearanceRecurrent lung infectionsThrush or persistent fungal infections in the mouthLow levels of infection-fighting cells in the bloodNeed for intravenous feedingSepsis or bloodstream infections

Clinical phenotype terms (30)— hover any for plain English
Gastrointestinal atresiaHP:0002589Severe combined immunodeficiencyHP:0004430Ectopic calcificationHP:0010766Intestinal atresiaHP:0011100Jejunoileal ulcerationHP:0005229Bloody diarrheaHP:0025085Hypoplasia of the thymusHP:0000778Alopecia of scalpHP:0002293Recurrent abscess formationHP:0002722Rectal abscessHP:0005224Peritoneal abscessHP:0100592Abnormal ductus choledochus morphologyHP:0100889
Inheritance

Autosomal recessive

Passed on when both parents carry the same gene change; often skips generations

Age of Onset

Neonatal

Begins at or shortly after birth (first 4 weeks)

Orphanet ↗OMIM ↗NORD ↗

Treatments

1 available

Biktarvy

bictegravir, emtricitabine, and tenofovir alafenamide· Gilead Sciences, Inc.■ Boxed WarningOrphan Drug
as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg with an antiretroviral treatment history and n

as a complete regimen for the treatment of human immunodeficiency virus type 1 (HIV-1) infection in adults and pediatric patients weighing at least 14 kg with an antiretroviral treatment history and not virologically suppressed, with no known or suspected substitutions associated with resistance to the integrase strand inhibitor class, emtricitabine, or tenofovir

No actively recruiting trials found for Combined immunodeficiency-multiple intestinal atresia at this time.

New trials open frequently. Follow this disease to get notified.

Search ClinicalTrials.gov ↗Join the Combined immunodeficiency-multiple intestinal atresia community →

No specialists are currently listed for Combined immunodeficiency-multiple intestinal atresia.

View NORD Rare Disease Centers ↗Undiagnosed Disease Network ↗

Treatment Centers

8 centers
🏥 NORD

Baylor College of Medicine Rare Disease Center

Baylor College of Medicine

📍 Houston, TX

🏥 NORD

Stanford Medicine Rare Disease Center

Stanford Medicine

📍 Stanford, CA

🔬 UDN

NIH Clinical Center Undiagnosed Diseases Program

National Institutes of Health

📍 Bethesda, MD

🔬 UDN

UCLA UDN Clinical Site

UCLA Health

📍 Los Angeles, CA

🔬 UDN

Baylor College of Medicine UDN Clinical Site

Baylor College of Medicine

📍 Houston, TX

🔬 UDN

Harvard/MGH UDN Clinical Site

Massachusetts General Hospital

📍 Boston, MA

🏥 NORD

Mayo Clinic Center for Individualized Medicine

Mayo Clinic

📍 Rochester, MN

👤 Mayo Clinic Center for Individualized Medicine

🏥 NORD

UCLA Rare Disease Day Program

UCLA Health

📍 Los Angeles, CA

Financial Resources

1 resources
Biktarvy(bictegravir, emtricitabine, and tenofovir alafenamide)Gilead Sciences, Inc.

Travel Grants

No travel grants are currently matched to Combined immunodeficiency-multiple intestinal atresia.

Search all travel grants →NORD Financial Assistance ↗

Community

Open Combined immunodeficiency-multiple intestinal atresiaForum →

No community posts yet. Be the first to share your experience with Combined immunodeficiency-multiple intestinal atresia.

Start the conversation →

Latest news about Combined immunodeficiency-multiple intestinal atresia

No recent news articles for Combined immunodeficiency-multiple intestinal atresia.

Follow this condition to be notified when news becomes available.

Caregiver Resources

NORD Caregiver Resources

Support, advocacy, and financial assistance for caregivers of rare disease patients.

Mental Health Support

Rare disease caregiving can be isolating. Connect with counseling and peer support.

Family & Caregiver Grants

Financial assistance programs specifically for caregivers of rare disease patients.

Social Security Disability

Learn how rare disease patients may qualify for SSDI/SSI benefits.

Questions for your doctor

Bring these to your next appointment

  • Q1.How severe is my child's immune deficiency, and what specific infections should we watch for?,How much of the intestine is affected, and will my child ever be able to eat by mouth?,Is bone marrow transplantation an option for my child, and what are the realistic chances of success?,What genetic testing has been done, and should other family members be tested?,What are the long-term risks of total parenteral nutrition, and how can we minimize them?,Are there any clinical trials or experimental treatments available for this condition?,What support services are available for our family, including palliative care if needed?

Common questions about Combined immunodeficiency-multiple intestinal atresia

What is Combined immunodeficiency-multiple intestinal atresia?

Combined immunodeficiency with multiple intestinal atresia (CID-MIA) is an extremely rare and serious condition that affects both the immune system and the digestive tract. Babies born with this disease have a severely weakened immune system, meaning their body cannot properly fight infections. At the same time, they are born with multiple blockages (called atresias) in their intestines, where sections of the bowel are closed off or missing. These blockages prevent food from passing through normally and require surgical intervention shortly after birth. Because the immune system is so severel

How is Combined immunodeficiency-multiple intestinal atresia inherited?

Combined immunodeficiency-multiple intestinal atresia follows a autosomal recessive inheritance pattern. Genetic counseling can help families understand recurrence risk and testing options.

At what age does Combined immunodeficiency-multiple intestinal atresia typically begin?

Typical onset of Combined immunodeficiency-multiple intestinal atresia is neonatal. Age of onset can vary across affected individuals.

What treatment and support options exist for Combined immunodeficiency-multiple intestinal atresia?

1 patient support program are currently tracked on UniteRare for Combined immunodeficiency-multiple intestinal atresia. See the treatments and support programs sections for copay assistance, eligibility, and contact details.